AXA (CSP) AGM 2026 summary

Opening remarks and agenda

• The meeting opened with a tribute to Claude Bébéar and highlighted record earnings in 2025 despite a challenging environment.

• The agenda included strategic outlook, financial performance, governance, remuneration, Q&A, and voting on 21 resolutions.

• Legal formalities were completed, with a strong quorum of over 72% of shares represented.

Financial performance review

• Revenue reached EUR 116 billion in 2025, up 6% from 2024, with all business lines contributing.

• Underlying earnings grew by 9%, and the solvency ratio rose to 224%.

• Net income increased sharply due to the divestiture of AXA Investment Managers, generating a significant capital gain.

• The group outperformed major indices, and non-financial performance was tracked via the AXA for Progress Index.

Board and executive committee updates

• The board proposed renewing Thomas Buberl’s term as CEO for four years and appointing Philomena Colatrella as a new director.

• Ewout Steenbergen was appointed Chair of the Audit Committee, and several director terms were renewed.

• The board maintained a focus on diversity, independence, and expertise, with 14 directors post-meeting.